Blueprint Medicines Q4 2017 Earnings Report

Total Revenue
$1.63M
Previous year: $7.69M
-78.8%
EPS
-$1.23
Previous year: -$0.75
+64.0%

Blueprint Medicines

Blueprint Medicines